Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2021 Financial Results

Fourth Quarter 2021 Revenue of $65.9 million and Full Year 2021 Revenue of $209.3 million, Reflecting 22% Quarterly and 159% Annual Growth

Expanded Cannabis Footprint to Seven States, Including Three Vertically Integrated Markets

BOCA RATON, Fla., March 24, 2022 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, is pleased to announce its financial results for the fourth quarter 2021 (“Q4 2021”) and full year ended December 31, 2021 (“FY 2021”). All financial information is provided in U.S. dollars unless otherwise indicated.

Financial Highlights

Q4 2021 

• Total revenue of $65.9 million, an increase of 22% sequentially and 104% year-over-year
• Adjusted gross profit⁽¹⁾ of $26.4 million, an increase of 8% sequentially and 76% year-over-year
• Net income of $9.1 million, or $0.05 per basic share with net loss per diluted share of $(0.14)
• Adjusted EBITDA⁽¹⁾ of $1.5 million
• Cash and cash equivalents were $95.0 million as of the quarter end

FY 2021

• Total revenue of $209.3 million increased approximately 159% year-over-year
• Adjusted gross profit⁽¹⁾ of $92.1 million, an increase of 144% year-over-year
• Net income of $25.3 million, an increase of $237.2 million year-over-year
• Adjusted EBITDA⁽¹⁾ of $16.9 million, or 8% of revenue, an increase of $16.3 million year-over-year

Fourth Quarter 2021 Operational Highlights

• Entered into a definitive agreement to acquire NuLeaf, Inc. (“NuLeaf”), a Nevada-based vertically integrated operator with three adult-use and medical retail dispensaries, a 27,000 sq. ft. cultivation facility, and a 13,000 sq. ft. processing facility
• Opened four BEYOND / HELLO™ retail locations and the Company’s 28^th store nationwide
• Secured a $100 million Senior Secured Credit Facility (the “Acquisition Facility”) from a portfolio company of SunStream Bancorp Inc.
• Appointed Edward Kremer to Chief Financial Officer

Recent Developments

• Completed the acquisition of The Apothecarium⁽²⁾ in Las Vegas, Nevada (“Apothecarium Nevada”), an operating adult-use and medical retail dispensary, establishing the Company’s fourth vertically integrated state-level operation and expanded national operating store count to 29
• Debuted a series of cannabis brands and product launches in Massachusetts
• Selected in the retail lottery for a provisional medical marijuana dispensary license in Clermont County, Ohio located in the Tri-State area of Cincinnati, awaiting certification as well as issuance of licenses by The Ohio Board of Pharmacy
• Closed a non-brokered private placement (the “Offering”), for total proceeds of approximately $13.7 million
• Announced that Jim Cacioppo, Chief Executive Officer, Chairman, and Founder, purchased 66,800 Class B Subordinate Voting Shares of the Company in the open market for an approximate amount of $220,000

Management Commentary

We closed out the year with another quarter of solid top-line revenue growth,” said Jim Cacioppo, Chief Executive Officer, Chairman, and Founder of Jushi. Throughout 2021, we made significant progress scaling our operations and positioning our platform for sustained growth and market leadership. During the year, we nearly doubled our operational retail store count through organic and inorganic expansion opportunities and bolstered and expanded our cultivation and processing capabilities with the addition of various assets across both our core and developing markets.”

Jim Cacioppo continued, “Over the fourth quarter, we incurred additional operating expenses as we invested in the business to support our long-term growth outlook, which ultimately resulted in lower profitability than initially anticipated. The reduction in profitability in the fourth quarter was largely due to costs associated with bringing on and fostering the right talent to strengthen the organization, along with an increase in headcount associated with new store openings and the build-out of our cultivation and processing assets. Along with investing in the business, we have also begun executing several cost savings measures that are expected to result in significant savings in the coming quarters.”

Jim Cacioppo concluded, “Now with 29 stores open and operating, licenses to open another 11 stores⁽³⁾, approximately 248 thousand square feet of operational cultivation and processing capacity, and an additional 82 thousand square feet anticipated to come online this year, we expect to cement our retail network and rapidly expand our wholesale business in some of the most exciting markets in the U.S. We are incredibly proud our people and the platform we have built, and we are ready to build on this momentum into 2022 and beyond as we position Jushi for the future.”

⁽¹⁾  See “Reconciliation of Non-IFRS Financial Measures” at the end of this press release for more information regarding the Company’s use of non-IFRS financial measures and reconciliations of the same to IFRS financial measures.
⁽²⁾  The Apothecarium is used under license with an affiliate of TerrAscend Corp.
⁽³⁾  Includes assets under a Definitive Agreement.

Financial Results for the Fourth Quarter Ended December 31, 2021

The following is a tabular summary and commentary of revenue, gross profit, adjusted gross profit⁽¹⁾, net income (loss), and net income (loss) per share for the three-month periods ended December 31, 2021, September 30, 2021, and December 31, 2020.

Revenue in Q4 2021 was $65.9 million, an increase of 22% as compared to $54.0 million in the third quarter of 2021 (“Q3 2021”) and increased 104% from $32.3 million in the fourth quarter of 2020 (“Q4 2020”). The 22% sequential growth in revenue was primarily driven by the acquisition of Nature’s Remedy in Massachusetts, strong revenue growth at the Company’s BEYOND / HELLO™ stores in Virginia and Illinois, and increased wholesale activity at the Company’s grower-processor facilities in Pennsylvania and Virginia.

Adjusted gross profit⁽¹⁾ in Q4 2021 was $26.4 million, or 40.0% of revenue, compared to $24.4 million, or 45.1% of revenue, in Q3 2021. The decrease in gross margin was primarily driven by price compression at the retail level in Pennsylvania and Illinois and at the wholesale level due to increased promotional activity as the Company continues to build-out its brands across state markets. The Company also recorded additional period end adjustments related to the establishment of a reserve for expiring product and plant attrition incurred in the normal course, which negatively impacted gross margin.

Q4 2021 net income was $9.1 million, or $0.05 per basic share and net loss of $0.14 per diluted share, compared to net income of $38.2 million, or $0.23 per basic share and net loss of $0.08 per diluted share, in Q3 2021. The net loss of $0.14 per diluted share in Q4 2021 was primarily due to the dilutive effects of the derivative warrants as accounted for under IFRS. The fair value gain on the derivative warrants is removed from basic earnings to calculate diluted net loss, which is then divided by the diluted weighted average number of shares.

Adjusted EBITDA⁽¹⁾ in Q4 2021 was $1.5 million, as compared to $6.4 million in Q3 2021 and $3.8 million in Q4 2020. The decline in Adjusted EBITDA⁽¹⁾ was primarily driven by an increase in operating expenses due to increased investments to support the Company’s long-term growth outlook, and lower gross profit driven by retail and wholesale margin compression.

Financial Results for the Year Ended December 31, 2021

The following is a tabular summary and commentary of revenue, gross profit, adjusted gross profit⁽¹⁾, net income (loss), and net income (loss) per share for the twelve-month periods ended December 31, 2021, and December 31, 2020.        

($ in millions, except per share amounts) 

FY 2021 revenue increased 159% to $209.3 million, compared to $80.8 million in 2020. The 159% increase in revenue was primarily driven by the build-out and expansion of the Company’s retail operations in Pennsylvania and Illinois, the acquisition of Nature’s Remedy, and a modest expansion of the Company’s wholesale business in both Pennsylvania and Virginia. During FY 2021, the Company opened 13 stores across five markets, ending the year with 28 operating stores.

FY 2021 adjusted gross profit⁽¹⁾ was $92.1 million, or 44.0% of revenue, compared to $37.7 million or 46.7% of revenue in 2020. The increase in adjusted gross profit⁽¹⁾ was driven by the Company’s expanded retail business, including the addition of 13 new stores, and increased distribution of Jushi’s branded products into the wholesale market.

FY 2021 net income was $25.3 million, or $0.40 loss per diluted share, compared to a net loss of $211.9 million, or $(2.11) per diluted share, in 2020.

Adjusted EBITDA⁽¹⁾ for FY 2021 was $16.9 million, an increase of $16.3 million compared to $0.7 million in 2020.

Balance Sheet and Liquidity

As of December 31, 2021, the Company had $95.0 million of cash and cash equivalents. On a pro forma basis, including proceeds from the Offering closed in the first quarter of 2022, the Company had $108.6 million of cash and cash equivalents as of December 31, 2021. The Company incurred approximately $18.0 million in cash capital expenditures during Q4 2021 and approximately $74.3 million for FY 2021. The Company expects to incur approximately $40 to $60 million in cash capital expenditures for the full year 2022, subject to market conditions and regulatory changes, of which a portion will be funded by an existing financing arrangement. As of December 31, 2021, the Company had $147 million principal amount of total debt, excluding leases and property, plant, and equipment financing obligations. As of December 31, 2021, the Company’s Acquisition Facility had $85 million of available capacity, including the $25 million accordion feature. As of March 24, 2022, the Company’s issued and outstanding shares were 189,720,812 and its fully diluted shares outstanding were 276,686,790.

Outlook

Mr. Cacioppo commented, “After reporting strong sequential revenue growth in the fourth quarter of 2021, we are experiencing a slowdown in revenue as we begin the year. Additionally, due to a combination of headwinds, including seasonality, macroeconomic factors, regulatory delays, and supply chain issues, we are revising our previously provided guidance range to an annualized fourth quarter 2022 run-rate. We now expect fourth quarter revenue on an annualized basis to be between $375 to $425 million and Adjusted EBITDA to be between $70 to $90 million on an IFRS basis.”

The Company’s MD&A and consolidated financial statements for the fourth quarter and year ended December 31, 2021, will be filed in April. The Company’s previous public filings may be found on SEDAR at www.SEDAR.com.

Conference Call and Webcast Information

The Company will host a conference call to discuss its financial results for the fourth quarter and full year 2021 at 9:00 a.m. ET today, Thursday, March 24, 2022.

For interested individuals unable to join the conference call, a dial-in replay of the call will be available until April 20, 2022, and can be accessed by dialing +1-844-512-2921 (U.S. Toll-Free) or +1-412-317-6671 (International) and entering replay pin number: 13727396.

Consolidated Financial Statements

The financial information reported in this press release is based on unaudited management prepared financial statements for the three months and year ended December 31, 2021. These financial statements have been prepared in accordance with IFRS. This release contains certain preliminary financial results for fourth quarter and full-year 2021, including, but not limited to, Cost of goods sold; Gross profit; Other income (expense), net, including impairment charges; Income tax (expense) benefit; Net loss; Inventory, net; Goodwill, net; Deferred taxes, contingent consideration and other payables, short-term. The Company expects to file its audited consolidated financial statements for the year ended December 31, 2021, on SEDAR in April. Accordingly, such financial information may be subject to change. All financial information contained in this press release is qualified in its entirety with reference to such financial statements. While the Company does not expect there to be any material changes between the information contained in this press release and the consolidated financial statements it files on SEDAR, to the extent that the financial information contained in this press release is inconsistent with the information contained in the Company’s financial statements, the financial information contained in this press release shall be deemed to be modified or superseded by the Company’s filed financial statements. The making of a modifying or superseding statement shall not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation for purposes of applicable securities laws. Further, the reader should refer to the additional disclosures in the Company’s audited financial statements for the year ended December 31, 2021, expected to be filed on SEDAR in April.